Your browser doesn't support javascript.
loading
Targeted protein degrader development for cancer: advances, challenges, and opportunities.
Fang, Yuan; Wang, Shuhang; Han, Songzhe; Zhao, Yizhou; Yu, Cunjing; Liu, Huaqing; Li, Ning.
Afiliación
  • Fang Y; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang S; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Han S; Department of Chemistry, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Zhao Y; Department of Chemistry, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Yu C; Translational Discovery, Research, and Medicine, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Liu H; Department of Chemistry, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Li N; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: ncctrials@cicams.ac.cn.
Trends Pharmacol Sci ; 44(5): 303-317, 2023 05.
Article en En | MEDLINE | ID: mdl-37059054
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Trends Pharmacol Sci Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Trends Pharmacol Sci Año: 2023 Tipo del documento: Article País de afiliación: China